Study directory

Bipolarity studies

Compare studies and check their requirements with the research team.

Back to overview

1909studies shown

Showing 1,309-1,320 of 1,909

CompletedNCT00650611

Safety study of ziprasidone in Schizophrenia

This study is completed in the United States. It is testing ziprasidone for Schizophrenia.

Multiple locations, including San Diego

Why is this study shown?

This study includes Bipolarity among several conditions.

Schizophrenia, BipolarityDrugFrom 10 Years to 17 Years

Countries: United States
Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Condition: Schizophrenia, Bipolarity

View study

CompletedNCT00621777

Varenicline for Prevention of Relapse to Smoking in people with Schizophrenia or Bipolarity

This study is completed in the United States. It is testing varenicline for schizophrenia.

Multiple locations, including Birmingham

Why is this study shown?

This study includes Bipolarity among several conditions.

Bipolarity, SchizophreniaDrugFrom 18 Years to 70 Years

Countries: United States
Sponsor: Massachusetts General Hospital
Condition: Bipolarity, Schizophrenia

View study

CompletedNCT00812058

Safety study of Safety, Tolerability and Efficacy of RG2417 in depression

This study is completed in the United States. It is testing Safety, Tolerability and Efficacy of RG2417 for depression.

Multiple locations, including Birmingham

Why is this study shown?

This study includes Bipolarity among several conditions.

Bipolarity, DepressionDrugFrom 18 Years to 65 Years

Countries: United States
Sponsor: Repligen Corporation
Condition: Bipolarity, Depression

View study

CompletedNCT03692910

SAGE-217 in people with Bipolar I/II Disorder With a Current Major Depressive Episode

This study is completed in the United States. It is testing SAGE-217 for depression.

Multiple locations, including Little Rock

Why is this study shown?

This study includes Bipolarity among several conditions.

Bipolarity, DepressionDrugFrom 18 Years to 65 Years

Countries: United States
Sponsor: Biogen
Condition: Bipolarity, Depression

View study

CompletedNCT04427137

Accelerated LFR for Bipolar Patients During the COVID-19 Pandemic

This summary needs review. Please check the official study record and contact the research team for details.

In Toronto

Why is this study shown?

This study includes Bipolarity among several conditions.

Bipolarity, DepressionDeviceOver 18 Years

Countries: Canada
Sponsor: Centre for Addiction and Mental Health
Condition: Bipolarity, Depression

View study

CompletedNCT01133821

Acute Psychotherapy for Bipolar II Depression

This summary needs review. Please check the official study record and contact the research team for details.

In Pittsburgh

Why is this study shown?

This study includes Bipolarity among several conditions.

Bipolarity, DepressionDrugFrom 18 Years to 65 Years

Countries: United States
Sponsor: Holly Swartz
Condition: Bipolarity, Depression

View study

CompletedNCT00074776

Acute Treatment of Bipolar II Depression

This summary needs review. Please check the official study record and contact the research team for details.

In Dallas

Why is this study shown?

This study includes Bipolarity among several conditions.

Bipolarity, DepressionDrugFrom 18 Years to 55 Years

Countries: United States
Sponsor: Stanford University
Condition: Bipolarity, Depression

View study

CompletedNCT00483548

Adjunctive Ziprasidone in the Treatment of Bipolar I Depression

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including Chandler

Why is this study shown?

This study includes Bipolarity among several conditions.

Bipolarity, DepressionDrugOver 18 Years

Countries: United States, Australia, India
Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Condition: Bipolarity, Depression

View study

UnknownNCT05384405

aiTBS for Relieving NSSI in Depressive Patients

This summary needs review. Please check the official study record and contact the research team for details.

In Changsha

Why is this study shown?

This study includes Bipolarity among several conditions.

Depression, BipolarityDeviceFrom 12 Years to 18 Years

Countries: China
Sponsor: Central South University
Condition: Depression, Bipolarity

View study

CompletedNCT00102518

Aripiprazole Safety and Tolerability Study

This study is completed in the United States. It focuses on Schizophrenia.

Multiple locations, including Birmingham

Why is this study shown?

This study includes Bipolarity among several conditions.

Schizophrenia, BipolarityDrugFrom 10 Years to 17 Years

Countries: United States
Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc.
Condition: Schizophrenia, Bipolarity

View study

CompletedNCT00276965

Bipolar II Depression: Lithium, SSRI, or the Combination

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including Los Angeles

Why is this study shown?

This study includes Bipolarity among several conditions.

Bipolarity, DepressionDrugFrom 18 Years to 65 Years

Countries: United States
Sponsor: Lindner Center of HOPE
Condition: Bipolarity, Depression

View study

CompletedNCT00893841

Bipolar Study of Seroquel XR With Pramipexole Dihydrochloride

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including San Diego

Why is this study shown?

This study includes Bipolarity among several conditions.

Bipolarity, DepressionDrugFrom 18 Years to 65 Years

Countries: United States, Canada
Sponsor: Dr. D McIntosh & Dr. K Kjernisted Clinical Research Inc.
Condition: Bipolarity, Depression

View study

Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.